General Information of Drug (ID: DMY43FU)

Drug Name
PO3 2-Leu-Nal-O-3K
Synonyms CHEMBL280917
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 405.4
Logarithm of the Partition Coefficient (xlogp) 2.6
Rotatable Bond Count (rotbonds) 7
Hydrogen Bond Donor Count (hbonddonor) 2
Hydrogen Bond Acceptor Count (hbondacc) 7
Chemical Identifiers
Formula
C19H22N2O6P-3
IUPAC Name
(2S)-2-[[(2S)-4-methyl-2-(phosphonatoamino)pentanoyl]amino]-3-naphthalen-1-ylpropanoate
Canonical SMILES
CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC2=CC=CC=C21)C(=O)[O-])NP(=O)([O-])[O-]
InChI
InChI=1S/C19H25N2O6P/c1-12(2)10-16(21-28(25,26)27)18(22)20-17(19(23)24)11-14-8-5-7-13-6-3-4-9-15(13)14/h3-9,12,16-17H,10-11H2,1-2H3,(H,20,22)(H,23,24)(H3,21,25,26,27)/p-3/t16-,17-/m0/s1
InChIKey
RGBJIKYRFMBDCB-IRXDYDNUSA-K
Cross-matching ID
PubChem CID
91934756
TTD ID
D0ZY2T

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Endothelin-converting enzyme 1 (ECE1) TTQ9RYT ECE1_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Aminophosphonate endothelin converting enzyme inhibitors: potency-enhancing and selectivity-improving modifications of phosphoramidon, Bioorg. Med. Chem. Lett. 4(10):1257-1262 (1994).